Mar 5 • 01:50 UTC 🇺🇸 USA Fox News

Top Trump ally Steve Daines exits Montana Senate race, plans to retire

Senator Steve Daines of Montana has announced his decision not to seek reelection, opting to retire from the Senate just before the filing deadline.

Senator Steve Daines, a Republican from Montana, has confirmed that he will not run for reelection, a surprising move given his expected position as a strong candidate for a third term. Daines, who has been serving Montana in the Senate since 2015 after two terms in the House, made this announcement just moments before the filing deadline, leaving many within the Republican party contemplating the implications of his decision. His departure comes at a time when Republicans are keen on retaining control over both chambers of Congress after a successful electoral cycle in which Daines played a pivotal role as the chair of the National Republican Senatorial Committee.

In his statement, Daines expressed gratitude for the support of his wife, Cindy, and after 13 years in public office, he emphasized the personal reflection that led to his decision. Notably, Daines was instrumental in a significant Republican victory in 2024, during which President Trump garnered nearly a 20-point lead in Montana, solidifying the state’s Republican leanings. His retirement may shift the political landscape in Montana, raising questions about potential successors and the strategies the GOP will employ to maintain its dominance in the region.

Daines supported fellow Republican candidate Tim Sheehy in a competitive race against former Senator Jon Tester from the Democratic party. This move not only signifies Daines's influence within the state but also reflects a broader strategy within the Republican framework to consolidate power against Democratic challengers in upcoming elections. As Daines steps back, the dynamics of the Montana Senate race will be closely watched, particularly in how it may affect GOP momentum and candidate recruitment as they aim for unified control in Washington.

📡 Similar Coverage